Publications by authors named "C Lattard"
Article Synopsis
- Healthcare professionals are addressing challenges related to drug-related problems (DRPs) in patients undergoing oral anticancer therapy (OAT), including side effects and medication errors.
- The ONCORAL program provides a structured care plan with weekly consultations to help manage these DRPs during the first OAT cycle, involving interventions from nurses and pharmacists.
- Results indicated that 87.1% of patients received interventions, identifying numerous DRPs and leading to adjustments in medications, with an average relative dose intensity of 83.1% for the treatment cycle.
This is a systematic literature review on the impact of pharmacists in rheumatology, conducted using the PubMed, CINAHL, Cochrane Library, and Web of science databases and using the PRISMA 2020 checklist. This review was conducted from 2000 to June 2024. A quality analysis was performed.
View Article and Find Full Text PDFThe pediatric renal graft pathway is at risk of care discontinuation, even though therapeutic adherence is essential. The objective is to evaluate the integration of clinical pharmacy activities into this care pathway. This feasibility study is divided into three stages: structuring, implementing and evaluation.
View Article and Find Full Text PDFIntroduction: Recent advances in technology have made it possible to develop robots for preparing injectable anticancer drugs. This study aims to compare characteristics between robots available in the European market in 2022 and to help future pharmacy users in their choices.
Methods: Three sources of data were used: (1) a review of published articles in the MEDLINE database from November 2017 to end of June 2021 on chemotherapy-compounding robots used in hospital; (2) all manufacturers' documentation, and (3) demonstrations of robot operations in real hospital conditions and discussions with users and manufacturers.
Purpose: Clinical pharmacy can reduce drug-related iatrogenesis by improving the management of adverse effects of drugs, limiting drug-drug interactions, and improving patient adherence. Given the vulnerability of cancer patients and the toxicity of injectable anticancer drugs, clinical pharmacy service (CPS) could provide a significant clinical benefit in cancer care. This review aims to synthesize existing evidence on clinical pharmacy's impact on patients treated with intravenous anticancer drugs.
View Article and Find Full Text PDF